Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 75 of 3173 entries
View as:

A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients

Phase: N/A Priority: Normal
NCT ID: NCT01305239 Org: User:
Start: 10/31/08 End: 05/31/11 Due: 05/31/12

Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

Phase: N/A Priority: Normal
NCT ID: NCT00691483 Org: User:
Start: 09/30/08 End: 12/31/09 Due: 12/31/10

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00988598 Org: User:
Start: 10/26/09 End: 07/05/10 Due: 07/05/11

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT01176058 Org: User:
Start: 12/31/10 End: 11/30/11 Due: 11/30/12

A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329

Phase: N/A Priority: Normal
NCT ID: NCT00934089 Org: User:
Start: 01/31/10 End: 06/30/10 Due: 06/30/11

Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

Phase: N/A Priority: Normal
NCT ID: NCT00101686 Org: User:
Start: 02/28/03 End: 10/31/08 Due: 10/31/09

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT00488488 Org: User:
Start: 11/30/06 End: 03/31/10 Due: 03/31/11

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT04613375 Org: User:
Start: 03/12/21 End: 03/24/24 Due: 03/24/25

A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure

Phase: N/A Priority: Normal
NCT ID: NCT01787461 Org: User:
Start: 01/31/13 End: 03/31/14 Due: 03/31/15

A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00143286 Org: User:
Start: 04/30/03 End: 03/31/05 Due: 03/31/06

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Phase: N/A Priority: Normal
NCT ID: NCT06962969 Org: User:
Start: 06/30/25 End: 11/28/25 Due: 11/28/26

A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06799533 Org: User:
Start: 05/01/25 End: 06/07/30 Due: 06/07/31

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

Phase: N/A Priority: Normal
NCT ID: NCT00348673 Org: User:
Start: 02/28/06 End: 02/28/07 Due: 02/28/08

Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT05509894 Org: User:
Start: 06/20/24 End: 01/03/28 Due: 01/03/29

A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06686797 Org: User:
Start: 11/27/24 End: 08/04/25 Due: 08/04/26

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT06703190 Org: User:
Start: 11/25/24 End: 12/31/25 Due: 12/31/26

A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00971802 Org: User:
Start: 09/30/09 End: 02/28/10 Due: 02/28/11

Secondary Databased Post-marketing Surveillance Study of BNT162b2

Phase: N/A Priority: Normal
NCT ID: NCT06743334 Org: User:
Start: 04/23/25 End: 05/28/25 Due: 05/28/26

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT03938792 Org: User:
Start: 03/09/20 End: 04/29/25 Due: 04/29/26

A Renal Impairment Study for PF-06651600

Phase: N/A Priority: Normal
NCT ID: NCT04037865 Org: User:
Start: 08/19/19 End: 03/31/20 Due: 03/31/21

A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

Phase: N/A Priority: Normal
NCT ID: NCT00002325 Org: User:
Start: - End: - Due: -

Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of Esreboxetine

Phase: N/A Priority: Normal
NCT ID: NCT00800956 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

A Rollover Protocol of Dacomitinib For Patients In Japan

Phase: N/A Priority: Normal
NCT ID: NCT02382796 Org: User:
Start: 07/10/15 End: 05/30/19 Due: 05/30/20

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00628095 Org: User:
Start: 04/07/08 End: 02/04/09 Due: 02/04/10

A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01546038 Org: User:
Start: 06/27/12 End: 03/04/19 Due: 03/04/20